Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

What the Changes in DTC Spending Mean for Pharma Companies

Posted by Sharon Suchotliff on Mon, Nov 12, 2018

Hensley Evans co-wrote this blog post with Sharon Suchotliff. 

In our previous blog post, we shared three key trends that are driving direct-to-consumer marketing into a state of flux. These forces—the exit of big DTC spenders due to loss of exclusivity, specialty brands driving investment in TV only, and shifts in consumer behavior and marketing mix—are behind the 4.7% decline in spending that we saw between 2016 and 2017.

Read More

Topics: Pharma Industry, digital marketing, DTC, consumer behavior, customer engagement journeys, pharma brands, pharma marketers, direct-to-consumer marketing, marketing mix, TV advertising, DTC marketing

What Does a Good Forecasting Platform Look Like?

Posted by Matt Wills on Wed, Oct 03, 2018

This post is the third in a four-part series on how pharmaceutical companies can elevate their forecasting operations. To learn more about next-generation analytics in forecasting, check out Matt’s session at the ZS Impact Summit, held Nov. 6-7 in Chicago.

Advances in data availability and the technology needed to harness that data have led many to ask how new technology could be used to implement advanced forecasting platforms for regional or global use. These platforms are typically software that sits online to enhance a forecasting process, whether specific to a country or used globally. Often, these questions are focused on increasing the efficiency of the existing forecasting team. While increasing the efficiency is important, it typically doesn’t generate enough organizational impact relative to the investment required to build and maintain a sophisticated piece of software. Platforms should strive to enable better decisions faster and more broadly than just reducing forecaster effort.

Read More

Topics: forecasting, Pharma, Life Sciences, Analytics, forecasting in pharma, pharma marketers, forecasting platforms, Impact Summit 2018

Three Tips for Getting the Most From Your Brand Tracker

Posted by Sonal Singh on Fri, Sep 28, 2018

Brand performance tracking is an indispensable asset for helping pharmaceutical companies develop robust brand strategies. A strong brand tracker helps monitor changes in brand awareness and perception, shifts in competitive positioning, and the impact of marketing efforts over time. However, many pharma marketers feel that tracking studies require continuous upkeep but don’t provide a lot of value, and some marketers don’t know how to best use their trackers. 

Read More

Topics: marketing strategy, data, insights, pharma marketing, pharma brands, pharma marketers, Omnisight, brand tracking, brand performance tracker

System Change: The Path to Customer Centricity

Posted by Pete Mehr on Wed, Aug 08, 2018

This post is the third in a three-part series on how pharma companies can achieve customer centricity.

In our second blog post, we highlighted the difference between point change—where a change program is focused on a single, new capability—and system change, where the change program is focused on redesigning a process of how several capabilities work together. We see companies purchasing new capabilities—cloud-based marketing automation tools, digital asset management tools, data science capabilities, etc.—but introducing these capabilities via point change. This reinforces the siloed structure that most companies have today and limits the value of these new capabilities. The better approach is to recognize that these tools and capabilities are designed to be integrated, and to redesign the marketing process to be more automated and integrated across functions. In other words, use the tools and capabilities to break the silos by deploying them via system change.

Read More

Topics: customer centricity, change management, pharma companies, point change, customer-centric capabilities, customer-centric pharma organizations, system change, pharma marketers

What the GDPR Means for Pharma Marketers

Posted by Pinaki Chakrabarty on Mon, Aug 06, 2018

This year has been a watershed moment for data privacy. In March, the data of millions of Facebook users was harvested by the U.K.-based firm Cambridge Analytica, and was purportedly used to manipulate public opinion. While news of the Facebook/Cambridge Analytica situation went viral, it was just one of more than a dozen data breaches in 2018 alone, which have led to an increasing focus on users’ data privacy. 

Read More

Topics: customer experience, Facebook, GDPR, general data protection regulation, pharma marketers, data protection, data security, digital strategy, Cambridge Analytica

Subscribe to The Active Ingredient


Subscribe to receive email notifications whenever new blog posts are published.